Page results
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
Information for service users about the RESPOND service for refugees and asylum seekers.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
This page is for patients with obesity who are waiting for scheduled surgery.
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a video or telephone appointment.
-
Bed availability is a “significant” factor in determining whether or not a patient is admitted to a critical care bed after surgery, questioning whether some are getting the care they need, a new study from researchers at UCL and UCLH has found for the first time.
-
This page offers advice to patients who are feeling sick.
File results
-
FOI/2022/0768 - Patients treated for Haemophila A
-
FOI/2022/0681 - Deep brain stimulation procedure
-
FOI/2022/0665 - Formal patient/ family complaints
-
FOI/2022/0672 - Data Centre
-
FOI/2022/0674 - Maternity locum staffing
-
FOI/2022/0675 - Drug treatment for Paediatric patients (ages 0-16)
-
FOI/2022/0677 - Documents relating to the lift being out of order (RLHIM Lift 2 by reception)
-
FOI/2022/0679 - Theatre management, AA's and ODPs
-
FOI/2022/0696 - Trust complaints policy and discrimination and diversity policy
-
FOI/2022/0705 - Head/ neck and urothelial cancer treatment